Search Results 1111-1120 of 19309 for Hemoglobin

1. Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes - Mayo Clinic

   Phase I/II: Patients must have received ≥ 2 units of RBCs for hemoglobin ≤ 9.0 g/dL within 8 weeks prior to start of treatment. Patient is non-responsive ...

2. Ravulizumab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

   * Uncontrolled diabetes mellitus with glycosylated hemoglobin (HbA1c) \> 8.5%. * Clinically active Henoch-Schonlein purpura (IgA vasculitis) requiring ...

3. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (9 g/dL is equivalent to 90 g/L and 5.59 mmol/L). Hepatic: Total bilirubin ≤ 1.5 x the institutional upper limit of normal (ULN). For ...

4. Efficacy and Safety of Seralutinib in Adult Subjects With PAH - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) \< 45 mL/min/1.73m\^2 Hemoglobin (Hgb) concentration \< 8.5 g/dL at Screening. 19. Evidence of active or latent ...

5. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Participation eligibility · Hemoglobin ≥ 9.0 g/dL; · Neutrophils count ≥ 1.5 x10^9 /L; · Total lymphocytes count ≥ 0.5 x10^9 /L; · Platelets count ≥ 100 x10^9 / ...

6. A Study to Evaluate the Safety and Effectiveness of MOR202 in Anti-PLA2R Antibody-positive Membranous Nephropathy - Mayo Clinic

   Participation eligibility · Hemoglobin* < 90 g/L; · Thrombocytopenia**:. Platelets < 100.0 x 10^9 /L; · Neutropenia***: Neutrophils < 1.5 x 10^9 /L; · Leukopenia*** ...

7. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   hemoglobin ≥9 g/dL;; serum bilirubin ≤1.5 × upper limit of normal (ULN) or ≤ × ULN for patients with Gilbert's disease;; CrCl ≥30 mL/min as measured by 24 ...

8. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ECOG Performance Status grade of 0 or 1. Clinical laboratory values meeting the following criteria during the Screening Phase: HEMOTOLOGY. Hemoglobin. ≥ 8.0 ...

9. Actinium Therapy For Late-stage Aggressive Sarcomas - Mayo Clinic

   Hemoglobin ≥ 8 g/dL 4. Total bilirubin level ≤ 1.5 × upper limit of normal (ULN). 5. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ...

10. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    ... hemoglobin level that remains above ≥ 9 g/L for at least 2 weeks). Hematology; Platelet count. < 100 × 10^9/L. Hemoglobin. < 9 g/L. ANC. < 1.5 × 10^9/L.